(PDF) Homogeneous antibody-drug conjugates: DAR 2 anti sorted by
relevance

Admin26.08.2021

(PDF) Homogeneous antibody-drug conjugates: DAR 2 anti

9505
Admin08.08.2021

(PDF) Homogeneous antibody-drug conjugates: DAR 2 anti

60010
Admin21.08.2021

(PDF) Homogeneous antibody-drug conjugates: DAR 2 anti

Admin18.07.2021

(PDF) Homogeneous antibody-drug conjugates: DAR 2 anti

8006
Admin30.09.2021

(PDF) Homogeneous antibody-drug conjugates: DAR 2 anti

93010
Admin17.07.2021

(PDF) A Purification Strategy Utilizing Hydrophobic

1105
Admin17.09.2021

(PDF) Antibody- Drug Conjugates: The Last Decade

7303
Admin05.10.2021

(PDF) Harnessing a catalytic lysine residue for the one

64010
Admin17.07.2021

(PDF) Homogeneous antibody-drug conjugates: DAR 2 anti

2603
Admin21.09.2021

Antibodies | Free Full-Text | A Purification Strategy

4609
Admin20.07.2021

(PDF) Antibody-drug conjugates with dual payloads for

605
Admin06.08.2021

(PDF) Antibody- Drug Conjugates: The Last Decade

9609
Admin20.08.2021

(PDF) Antibody- Drug Conjugates: The Last Decade

8704
Admin12.07.2021

(PDF) A Versatile Chemo-Enzymatic Conjugation Approach

2802
Admin13.07.2021

LC-MS Challenges in Characterizing and Quantifying

5010
Admin25.07.2021

Pharmaceuticals | Free Full-Text | Antibody-Drug

8608
Admin25.08.2021

RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate

8604
Admin12.08.2021

Pharmaceuticals | Free Full-Text | Antibody-Drug

6103
Admin08.09.2021

Antibodies | Free Full-Text | A Purification Strategy

909
Admin28.08.2021

Antibodies | Free Full-Text | A Purification Strategy

9201
Admin29.08.2021

Reducing hydrophobicity of homogeneous antibody-drug

1004